Joshua Wollen, PharmD

Articles by Joshua Wollen, PharmD

Gonorrhea infection -- Image credit: nobeastsofierce | stock.adobe.com

A Comparative Review of Gepotidacin and Zoliflodacin for Treating Neisseria gonorrhoeae Infections

ByAnnie Man, MS, PharmD Candidate,Shantera Davis, PharmD, BCPS,Elisabeth M. Wang, PharmD, BCCP,Natalie Rosario, PharmD, MPH, BCACP,Pat Sangtong, PharmD Candidate,Joshua Wollen, PharmD

September 14th 2026

Peer Reviewed

Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.

Finerenone and the Future of Diabetes-Related Kidney Care

ByAndy Dang, PharmD Candidate,Natalie Rosario, PharmD, MPH, BCACP,Elisabeth M. Wang, PharmD, BCCP,Shantera Davis, PharmD, BCPS,K’bria Whaley, PharmD Candidate,Joshua Wollen, PharmD

July 15th 2025

Peer Reviewed

Finerenone emerges as a promising treatment for patients with diabetes and chronic kidney disease, significantly reducing cardiovascular and renal risks.